Techh.info/biomedtechnology hourly

Headlines

headlines texts
25.05.2019
06:11 News-Medical.NetBenefit of allogeneic stem cell transplantation in non-Hodgkin lymphoma remains unclear

The German Institute for Quality and Efficiency in Health Care has investigated whether patients suffering from non-Hodgkin lymphoma have (better) chances of recovery when stem cells from another person are transplanted.

Скрыть анонс
05:59 Google news Sci/TechFDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drug - CNBC

FDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drug  CNBCNovartis slaps $2M-plus pricetag on newly approved gene therapy Zolgensma—and cost watchdogs approve  FiercePharmaNo Miracle Drug Should Cost $2.1 Million  BloombergAt $2.1M, Novartis gene therapy will be world's most expensive drug  STATAt $2M, priciest ever medicine treats fatal genetic disease  SF GateView full coverage on Google News

Скрыть анонс
00:51 Reuters.com HealthFor Anderson family, an early bet on SMA gene therapy

When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

Скрыть анонс
00:35 Medscape.ComFDA OKs First Gene Therapy for Spinal Muscular Atrophy

A single, one-time infusion of onasemnogene abeparvovec-xioi (Zolgensma) can minimize the progression of SMA and improve survival in children younger than age 2 years — and will cost over $2 million.

Скрыть анонс
00:35 ReutersFor Anderson family, an early bet on SMA gene therapy

When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

Скрыть анонс
00:11 Reuters.com HealthSeniors who feel their life has purpose may live longer

(Reuters Health) - Seniors who feel their life has purpose may be less likely to die from heart, circulatory and digestive diseases and more likely to live longer, new data suggest.

Скрыть анонс
00:10 Google news Sci/TechGene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops - Investor's Business Daily

Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops  Investor's Business DailyZolgensma From Novartis Is The Most Expensive Drug Ever Approved : Shots - Health News  NPRThe US just approved a $2.1 million treatment for a devastating disease. It's the most expensive drug in the world.  Business InsiderFDA approves new $2.125 million drug, the most expensive medicine ever, to treat rare condition in babies  Chicago TribuneNovartis wins approval for world’s most expensive drug  Financial TimesView full coverage on Google News

Скрыть анонс
24.05.2019
23:30 Reuters.com HealthNovartis $2 million gene therapy for rare disorder is world's most expensive drug

ZURICH/NEW YORK - Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million.

Скрыть анонс
23:27 ReutersNovartis $2 million gene therapy for rare disorder is world's most expensive drug

ZURICH/NEW YORK - Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million.

Скрыть анонс
23:03 Google news Sci/TechAt $2.1M, Novartis gene therapy will be world's most expensive drug - STAT

At $2.1M, Novartis gene therapy will be world's most expensive drug  STATGene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock Pops  Investor's Business DailyThis New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million.  The New York TimesFDA approves $2M medicine, most expensive ever  SF Gate$2.1 million drug to treat rare genetic disease approved by FDA  NBC NewsView full coverage on Google News

Скрыть анонс
23:01 CNN HealthGene therapy gets FDA approval -- and a $2 million price tag

The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.

Скрыть анонс
22:50 ScienceMag.orgHouse spending panel drops U.S. ban on gene-edited babies

Change would allow FDA to consider controversial treatments

Скрыть анонс
21:44 Reuters.com HealthIncyte's Jakafi wins FDA nod to treat complication of stem cell transplant

The U.S. Food and Drug Administration on Friday approved Incyte Corp's treatment for acute graft-versus-host disease, a complication from stem cell transplant.

Скрыть анонс
21:29 CNBC health careFDA approves Novartis' $2 million gene therapy for spinal muscular atrophy

The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting one in every 11,000 live births.

Скрыть анонс
20:23 Reuters.com HealthU.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorder

ZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, the company said on Friday, a one-time treatment expected to push the pricing boundary for rare diseases to new heights.

Скрыть анонс
20:19 ReutersU.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorder

ZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, the company said on Friday, a one-time treatment expected to push the pricing boundary for rare diseases to new heights.

Скрыть анонс
20:09 Reuters.com HealthU.S. approves Novartis gene therapy for rare, deadly muscle disorder

NEW YORK/ZURICH - Swiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, the company said on Friday, a one-time treatment expected to push the pricing boundary for rare diseases to new heights.

Скрыть анонс
20:08 CNBC top newsFDA approves Novartis' $2 million gene therapy for spinal muscular atrophy

The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting one in every 11,000 live births.

Скрыть анонс
16:53 News-Medical.NetCell scientist receives $1.9 million NIH grant to study muscle regeneration

As people age, their muscle regeneration capacity declines in part because they can no longer make enough muscle stem cells to replace damaged tissue.

Скрыть анонс
15:47 Phys.orgA 'crisper' method for gene editing in fungi

CRISPR/Cas9 is now a household name associated with genetic engineering studies. Through cutting-edge research described in their paper published in Scientific Reports, a team of researchers from Tokyo University of Science, Meiji University, and Tokyo University of Agriculture and Technology, led by Dr. Takayuki Arazoe and Prof Shigeru Kuwata, has recently established a series of novel strategies to increase the efficiency of targeted gene disruption and new gene "introduction" using the CRISPR/Cas9 system in the rice blast fungus Pyricularia (Magnaporthe) oryzae. These strategies include quicker (single-step) gene introduction, use of small homologous sequences, and bypassing of certain prerequisite host DNA "patterns" and host component modification.

Скрыть анонс
13:14 News-Medical.NetAMSBIO introduces next-generation feeder-free medium for pluripotent stem cell culture

AMSBIO introduces StemFit Basic04, a next-generation feeder-free medium for the maintenance of Induced Pluripotent Stem and Embryonic Stem cells during the reprogramming, expansion and differentiation phases of stem cell culture.

Скрыть анонс
11:36 Nature.ComAuthor Correction: A CRISPR/Cas system mediates bacterial innate immune evasion and virulence

Скрыть анонс
11:12 News-Medical.NetWFIRM researchers engineer vascularized functional renal tissues for kidney regeneration

Wake Forest Institute for Regenerative Medicine researchers have shown the feasibility of bioengineering vascularized functional renal tissues for kidney regeneration, developing a partial augmentation strategy that may be a more feasible and practical approach than creating whole organs.

Скрыть анонс
10:31 News-Medical.NetResearchers develop simple, quick technique for gene editing in rice blast fungus

CRISPR/Cas9 is now a household name associated with genetic engineering studies.

Скрыть анонс
09:26 Technology.orgCRISPR Fingers Drug-Resistant Microbes in a ‘FLASH’

A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a

Скрыть анонс
04:13 ScienceDaily.comAllogeneic stem cell transplantation in non-Hodgkin lymphoma: Benefit remains unclear

Meaningful studies are lacking for certain patient groups. Disease-specific registries could help close the data gap.

Скрыть анонс
23.05.2019
22:47 TechnologyReview.comGene therapy may have its first blockbuster

Novartis awaits approval to sell Zolgensma to treat spinal muscular atrophy.

Скрыть анонс
20:40 ScienceDaily.comNew 3D-printed technology lowers cost of common medical test

A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid 'washing the dishes' led researchers to develop a new technology that reduces cost and time. The 3D-printed pipette-tip test developed by the researchers leverages what 'has long been the gold standard for measuring proteins, pathogens, antibodies and other biomolecules in complex matrices,' they say. The method still employs the enzyme-linked immunosorbent assay, also known as ELISA, but through a different route.

Скрыть анонс
20:05 Phys.orgPlant stem cells require low oxygen levels

Plants function as the green lungs of our planet, and rightfully so, as the capacity of a large, single tree releases more than 120 kg of oxygen into the Earth's atmosphere every year through a series of sunlight-fuelled reactions in photosynthesis. However during flood events, plant tissues may experience severe oxygen shortage, a stressful situation that every year leads to substantial loss in yield for all major crops such as rice, wheat and barley.

Скрыть анонс
19:46 ScienceDaily.comPlant stem cells require low oxygen levels

New research reveals that low oxygen is required for proper development of plants.

Скрыть анонс
18:52 ScienceDaily.comA 'crisper' method for gene editing in fungi

A team of researchers has recently established a series of novel strategies to increase the efficiency of targeted gene disruption and new gene 'introduction' using the CRISPR/Cas9 system in the rice blast fungus Pyricularia (Magnaporthe) oryzae.

Скрыть анонс
18:31 News-Medical.NetExperimental noninvasive tool assesses efficacy of stem cell transplantation

Stem-cell based therapies to strengthen the heart muscle and treat other diseases are beginning to show promise in human clinical trials.

Скрыть анонс
17:18 SingularityHub.ComNew Progress in Stem-Cell-Free Regenerative Medicine

Regenerative medicine and stem cells are often uttered within the same breath, for good reason. In animal models, stem cells have reliably reversed brain damage from Parkinson’s disease, repaired severed spinal cords, or restored damaged tissue from diabetes, stroke, blood cancers, heart disease, or aging-related tissue damage. With the discovery of induced pluripotent stem cells […]

Скрыть анонс
16:03 Phys.orgCRISPR/Cas9 improves with better gene knockout method in aneuploid cell lines

CRISPR/Cas9 technology enables convenient and effective genome editing in diploid cell lines based on the isolation and expansion of edited single-cell clones. However, this approach is ineffective for aneuploid cell lines, and a group has now reported an improved method for genome editing based on multiple rounds of modification. The article is published in Tissue Engineering.

Скрыть анонс
14:37 NewScientist.ComRobots conduct daily health inspections of schoolchildren in China

Thousands of preschools in China are using robots to give students heath checks. Each morning they examine pupils looking for signs of contagious diseases

Скрыть анонс
11:22 Technology.org3D-printed device detects biomarkers of preterm birth

Preterm birth (PTB) — defined as birth before the 37th week of gestation — is the leading complication of pregnancy. If

Скрыть анонс
09:32 Technology.orgA new approach to targeting cancer cells

A University of California, Riverside, research team has come up with a new approach to targeting cancer cells

Скрыть анонс
03:56 ScienceDaily.comA road map to stem cell development

Researchers have developed a way to map retinal cell development and potentially advance regenerative medicine.

Скрыть анонс
02:50 ScienceDaily.com3D-printed device detects biomarkers of preterm birth

Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy. If doctors had a simple, accurate and inexpensive way to identify women at risk for the condition, they could develop better prevention strategies. Now researchers have created a 3D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of PTB.

Скрыть анонс
02:50 ScienceDaily.comExperimental noninvasive tool monitors effectiveness of stem cell transplantation

Other than clinical observations, the stem cell field lacks a repeatable, time-sensitive, noninvasive tool to assess the effectiveness of transplanted cells in the targeted organ. Researchers analyzed biomarkers secreted from transplanted human stem cells in the recipient blood of a rodent model of heart attack. Analysis of the blood test showed responding cells had changed their gene expression, behavior and secretions, suggesting this liquid biopsy could provide a window into stem cell activity and effectiveness.

Скрыть анонс
00:44 Reuters.com HealthNovartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range

Novartis AG's top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.

Скрыть анонс
22.05.2019
21:12 Nanowerk.comNew 3D-printed technology lowers cost of common medical test

A desire for a simpler, cheaper way to do common laboratory tests for medical diagnoses and to avoid 'washing the dishes' led researchers to develop a new technology that reduces cost and time.

Скрыть анонс
20:18 News-Medical.NetNovel 3D-printed device detects preterm birth biomarkers

Preterm birth -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy. If doctors had a simple, accurate and inexpensive way to identify women at risk for the condition, they could develop better prevention strategies.

Скрыть анонс
19:00 Phys.org3-D-printed device detects biomarkers of preterm birth

Preterm birth (PTB)—defined as birth before the 37th week of gestation—is the leading complication of pregnancy. If doctors had a simple, accurate and inexpensive way to identify women at risk for the condition, they could develop better prevention strategies. Now researchers have created a 3-D-printed microchip electrophoresis device that can sensitively detect three serum biomarkers of PTB. They report their results in ACS' journal Analytical Chemistry.

Скрыть анонс
18:05 Google news Sci/TechScientists Modify Viruses With CRISPR To Create New Weapon Against Superbugs - NPR

Scientists Modify Viruses With CRISPR To Create New Weapon Against Superbugs  NPR Alphonso Evans rolls his wheelchair into a weight machine in the gym at the Charlie Norwood VA Medical Center in Augusta, Ga. "I'm not so much worried about ...

Скрыть анонс
17:59 ScienceDaily.comNewly discovered hybrid molecules could serve as a novel category of anti-cancer agent

Researchers have developed and studied the biological activity of five new, metal-organic hybrid knotted molecules, termed metal-organic trefoil knots (M-TKs). These molecules can effectively deliver metals to cancer cells, demonstrating the potential to act as a new category of anti-cancer agents.

Скрыть анонс
17:47 Nature.ComCRISPR-baby rules, fake-news law and kilogram retires

Скрыть анонс
16:53 Nature.ComCRISPR zeroes in on antibiotic-resistance genes

Скрыть анонс
16:05 Reuters.com HealthRegenerative medicine firm CollPlant launches Israel R&D center

CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development center in Israel.

Скрыть анонс
16:03 News-Medical.NetNewly discovered molecules safely halt the gene editing process

Scientists have discovered two non-toxic molecules that safely halt the CRISPR-Cas9 gene editing process.

Скрыть анонс
14:04 Phys.orgNewly discovered hybrid molecules could serve as a novel category of anti-cancer agent

Researchers from NYU Abu Dhabi's (NYUAD) chemistry program and colleagues from the University's biology program have developed and studied the biological activity of five new, metal-organic hybrid knotted molecules, termed metal-organic trefoil knots (M-TKs). These molecules can effectively deliver metals to cancer cells, demonstrating the potential to act as a new category of anti-cancer agents.

Скрыть анонс
14:01 News-Medical.NetInhibition of CRMP2 phosphorylation promotes axonal regeneration after optic nerve injury

A new study by Professor Toshio Ohshima of Waseda University has found that the inhibition of phosphorylation of collapsing response mediator protein 2, a microtubule-binding protein, suppresses degeneration of nerve fibers and promotes its regeneration after optic nerve injury.

Скрыть анонс
11:47 Technology.orgScientists use molecular tethers and chemical ‘light sabers’ to construct platforms for tissue engineering

Tissue engineering could transform medicine. Instead of waiting for our bodies to regrow or repair damage after an

Скрыть анонс
11:45 MedicalNewsToday.comMedical News Today: 'Mediterranean diet may protect against depression symptoms'

Research presented at the American Psychiatric Association conference finds a link between Mediterranean diets and a lower depression risk later in life.

Скрыть анонс
11:23 News-Medical.NetUW researchers use molecular tethers, chemical 'light sabers' for tissue engineering

Tissue engineering could transform medicine. Instead of waiting for our bodies to regrow or repair damage after an injury or disease, scientists could grow complex, fully functional tissues in a laboratory for transplantation into patients.

Скрыть анонс
08:40 News-Medical.NetInhibition of CRMP2 phosphorylation supports optic nerve regeneration after injury

A new study by Professor Toshio Ohshima of Waseda University has found that the inhibition of phosphorylation of collapsing response mediator protein 2, a microtubule-binding protein, suppresses degeneration of nerve fibers and promotes its regeneration after optic nerve injury.

Скрыть анонс
07:07 GizmagPlacental stem cells found to regenerate heart cells after heart attack


Broken hearts are notoriously difficult to repair. After a heart attack this vital organ remains damaged, which can eventually lead to heart failure and death. Now, researchers have managed to use placental stem cells to regenerate heart cells in mice, which could lead to groundbreaking new treatments for heart attack victims.
.. Continue Reading Placental stem cells found to regenerate heart cells after heart attack Category: Medical Tags: Cells Heart Heart attack Heart Disease Mount Sinai Hospital Stem Cells

Скрыть анонс
06:02 ScienceDaily.comStem cell differences could explain why women are more likely to develop adrenal cancer

Scientists have discovered a potential biological reason why women are more likely to develop adrenal disorders, including cancer. According to the researchers, the answer could lie in the increased turnover of hormone-producing cells found in the adrenal glands of females.

Скрыть анонс
05:31 WhatReallyHappened.comChina set to impose regulations on gene-editing following controversial trial with human embryos

After global backlash involving the use of gene-editing tool CRISPR on human embryos, China will further tighten regulation on manipulating the human genome.
According to a report in Nature, a draft of new code in the country's civil law explicitly lists human genes and embryos as protected personal rights for the first time ever.
Lawyers interviewed by Nature say that the law would make any doctor or scientist engaging in the editing of the human genome liable for the outcome of their experiments.

Скрыть анонс
01:30 TechInvestorNews.comWe need to resolve ethics of CRISPR technology as China awaits third genetically modified baby (CNBC: Top News)

CNBC: Top NewsWe need to resolve ethics of CRISPR technology as China awaits third genetically modified baby - The scientific community is now struggling to grapple with the ethics of human germline editing as another woman pregnant with a gene-edited baby is soon due to give birth. ...

Скрыть анонс
00:41 TechInvestorNews.comGoogle built an AI that detects lung cancer better than human doctors (Mike Wehner/Boy Genius Report)

Mike Wehner / Boy Genius ReportGoogle built an AI that detects lung cancer better than human doctors - Science fiction has taught us to fear the inevitable rise of digital brains, and while its true that handing too much power to machines of our own creation could end badly, AI is proving itself to be an incredible tool for improving lives. The New York Times reports that one ...

Скрыть анонс
00:41 CNBC health careWe need to resolve ethics of CRISPR technology as China awaits third genetically modified baby

The scientific community is now struggling to grapple with the ethics of human germline editing as another woman pregnant with a gene-edited baby is soon due to give birth.

Скрыть анонс
00:29 CNBC top newsWe need to resolve ethics of CRISPR technology as China awaits third genetically modified baby

The scientific community is now struggling to grapple with the ethics of human germline editing as another woman pregnant with a gene-edited baby is soon due to give birth.

Скрыть анонс
00:12 ScienceDaily.comCertain placental stem cells can regenerate heart after heart attack

Researchers have identified a new stem cell type that can significantly improve cardiac function.

Скрыть анонс
21.05.2019
19:30 Medscape.ComMediterranean Diet May Keep Late-Life Depression at Bay

Adherence to a Mediterranean diet may guard against late-life depression, new research shows.

Скрыть анонс
19:18 News-Medical.NetLung cancer screening using Google AI proves to be successful

Researchers at Google have developed an algorithm that can successfully diagnose lung cancer in 94.4 percent of cases.

Скрыть анонс
17:59 ScienceDaily.comInhibition of protein phosphorylation promotes optic nerve regeneration after injury

Research results suggest that the inhibition of phosphorylation of microtubule-binding protein CRMP2 could be a novel approach to the development of treatments for optic neuropathies, such as glaucoma and traumatic injury.

Скрыть анонс
16:05 ScienceDaily.comScientists use molecular tethers, chemical 'light sabers' for tissue engineering

Researchers have unveiled a new strategy to keep proteins intact and functional in synthetic biomaterials for tissue engineering. Their approach modifies proteins at a specific point so that they can be chemically tethered to the scaffold using light. Since the tether can also be cut by laser light, this method can create evolving patterns of signal proteins throughout a biomaterial scaffold to grow tissues made up of different types of cells.

Скрыть анонс
15:53 ScienceDaily.comShedding light on cancer metabolism in real-time with bioluminescence

Cancerous tumors can be made to bioluminesce, like fireflies, according to the level of their glucose uptake, giving rise to a technique for quantifying metabolite absorption. The firefly imaging technique for sugar can be translated from cancer to many other metabolic diseases.

Скрыть анонс
14:17 Phys.orgScientists use molecular tethers and chemical 'light sabers' to construct platforms for tissue engineering

Tissue engineering could transform medicine. Instead of waiting for our bodies to regrow or repair damage after an injury or disease, scientists could grow complex, fully functional tissues in a laboratory for transplantation into patients.

Скрыть анонс
11:55 Nanowerk.comScientists use molecular tethers and chemical 'light sabers' to construct platforms for tissue engineering

Researchers unveiled a new strategy to keep proteins intact and functional by modifying them at a specific point so that they can be chemically tethered to the scaffold using light. Since the tether can also be cut by laser light, this method can create evolving patterns of signal proteins throughout a biomaterial scaffold to grow tissues made up of different types of cells.

Скрыть анонс
10:49 News-Medical.NetZebrafish may help researchers to use blood stem cells instead of bone marrow transplants

Blood diseases such as leukemia and lymphoma are currently treated with bone marrow transplants -- a transfer of blood stem cells from a healthy person to a patient in need.

Скрыть анонс
01:05 GizmagGoogle s AI for lung cancer diagnosis proves more accurate than radiologists in early trial


Like all forms of the disease, an early diagnosis of lung cancer can greatly improve a patient's chance of survival but, like all cancers this is much easier said than done. A Google research initiative aimed at harnessing artificial intelligence to better model and predict lung cancer has shown promise in a newly published study, with the technology even outperforming certified radiologists in some regards.
.. Continue Reading Google's AI for lung cancer diagnosis proves more accurate than radiologists in early trial Category: Medical Tags: Artificial Intelligence Cancer Google Lung cancer

Скрыть анонс
20.05.2019
22:32 TechInvestorNews.comGoogle built a lung cancer diagnosing AI and the implications are huge (Chris Davies/SlashGear)

Chris Davies / SlashGearGoogle built a lung cancer diagnosing AI and the implications are huge - An innovative system to predict lung cancer could make a huge change in survival rates, with Google exploring how artificial intelligence could dramatically improve diagnosis rates. Despite advances in cancer treatment, lung cancer remains one of the most deadly diseases, not least because difficulty in identifying it among patients means ...

Скрыть анонс
22:08 FierceBiotech.comMount Sinai researchers isolate placental cells that regenerate damaged hearts in mice

Researchers at the Icahn School of Medicine at Mount Sinai have shown in a study that Cdx2 cells from the placenta can migrate through the circulatory system and target heart injuries. In male mouse models of heart attack, the cells regenerated damaged tissue.

Скрыть анонс
19:40 MedicalNewsToday.comMedical News Today: Artificial intelligence better than humans at spotting lung cancer

New research shows that a form of artificial intelligence called deep learning detects lung cancer more accurately than radiologists can.

Скрыть анонс
19:40 BBC HealthArtificial intelligence diagnoses lung cancer

AI appears better than specialist doctors at diagnosing the disease from lung scans, say researchers.

Скрыть анонс
19:16 Google news Sci/TechGoogle's AI boosts accuracy of lung cancer diagnosis, study shows - STAT

Google's AI boosts accuracy of lung cancer diagnosis, study shows  STATA.I. Took a Test to Detect Lung Cancer. It Got an A.  The New York TimesGoogle’s lung cancer detection AI outperforms 6 human radiologists  VentureBeatView full coverage on Google News

Скрыть анонс
17:45 BBC HealthHarri Stickler: Transplant joy for baby with rare cancer

Harri Stickler is "doing great" after a donor was found following an appeal.

Скрыть анонс
14:13 Phys.orgIntensive silviculture accelerates Atlantic rainforest biodiversity regeneration

An experiment conducted in Brazil in an area of Atlantic Rainforest suggests that intensive silviculture, including the use of herbicide and substantial amounts of fertilizer, is a more effective approach to promoting the regeneration of tropical forest and biomass gain than the traditional method based on manual weeding and less fertilizer.

Скрыть анонс
13:10 Technology.orgResearchers identify molecules that rein in CRISPR systems

Scientists have identified the first chemical compounds able to inhibit and regulate CRISPR systems, which could ultimately make

Скрыть анонс
10:34 Nature.ComChina set to tighten gene-editing laws following CRISPR-baby furore

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
03:31 WhatReallyHappened.comBank of America Predicts Immortality Will Be Next Hot Investment

Скрыть анонс
17.05.2019
23:28 ScienceDaily.comA new approach to targeting cancer cells

A research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.

Скрыть анонс
20:42 MedicalNewsToday.comMedical News Today: Type 1 diabetes: New pancreatic cell transplant system shows promise

A new way of preparing insulin-producing implants of donor pancreatic cells promises to improve transplant effectiveness and reduce ensuing complications.

Скрыть анонс
18:03 WhatReallyHappened.comHow Equities Can Reduce Longevity Risk

Скрыть анонс
12:05 Technology.orgStudent develops an AI app to diagnose plant diseases

For some, a rose is a symbol of beauty or love. For Shaza Mehdi, it is a connection to

Скрыть анонс
11:01 News-Medical.NetStudy: All immature cells have potential to develop into stem cells

New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

Скрыть анонс
16.05.2019
23:48 Google news Sci/TechThe best Google Home commands for health, nutrition and fitness - CNET

The best Google Home commands for health, nutrition and fitness  CNET The complete list of commands for Google Home keeps growing, and while you may already use it to turn your lights on and off or stream TV, you can also ...

Скрыть анонс
22:56 ScienceDaily.comScientists find new type of cell that helps tadpoles' tails regenerate

Researchers have uncovered a specialized population of skin cells that coordinate tail regeneration in frogs. These 'Regeneration-Organizing Cells' help to explain one of the great mysteries of nature and may offer clues about how this ability might be achieved in mammalian tissues.

Скрыть анонс
22:22 News-Medical.NetStool transplant found safe and effective in children with C. difficile infections

Fecal microbiota transplant, or the transfer of stool from a healthy donor to a patient, has been found highly effective in reversing severe Clostridiodes difficile diarrheal infections in adults.

Скрыть анонс
21:58 News-Medical.NetPenn Medicine launches free, 'self-service' AI tool for data analytics

The Penn Medicine Institute for Biomedical Informatics has launched a free, open-source automated machine learning system for data analysis that is designed for anyone to use, from a high school student looking to gain insight on their baseball team's statistics, to trained researchers looking for associations between cancer and environmental factors.

Скрыть анонс
21:10 Phys.orgScientists find new type of cell that helps tadpoles' tails regenerate

Researchers at the University of Cambridge have uncovered a specialised population of skin cells that coordinate tail regeneration in frogs. These 'Regeneration-Organizing Cells' help to explain one of the great mysteries of nature and may offer clues about how this ability might be achieved in mammalian tissues.

Скрыть анонс
19:39 ScienceDaily.comFecal microbiota transplant found safe and effective in children with C. difficile

Fecal microbiota transplant (FMT), or the transfer of stool from a healthy donor to a patient, has been found effective in reversing severe, recurring diarrheal infections from Clostridiodes difficile in adults by restoring a normal microbiome. Now, the largest study to date of FMT in children finds the procedure to be safe and effective in eradicating an infection that is on the rise among children, even those without known risk factors.

Скрыть анонс
19:15 ScienceDaily.comSurprising research result: All immature cells can develop into stem cells

A new study challenges traditional knowledge of stem cell development. The study reveals that the destiny of intestinal cells is not predetermined, but instead determined by the cells' surroundings. The findings may make it easier to manipulate stem cells for stem cell therapy.

Скрыть анонс
17:06 Phys.orgAnalyzing brain waveforms using neuroimaging big data to improve diagnosis

A team of researchers from Osaka University and The University of Tokyo developed MNet, an automatic diagnosis system for neurological diseases using magnetoencephalography (MEG), demonstrating the possibility of making automatic neurological disease diagnoses using MEG. Their research results were published in Scientific Reports.

Скрыть анонс
17:06 Phys.orgNew power supply unit lets electrical devices live longer

From the charging unit for smartphones to the power supply of the laptop or washing machine to LED lights or charging stations of electric cars – switching power supplies are omnipresent in electrical devices. They convert the alternating current from the house line into the direct current needed by the device. The problem: power supplies are susceptible to errors, which also reduces the service life of end devices. Researchers of Karlsruhe Institute of Technology (KIT) have now developed a power supply unit with a significantly increased service life.

Скрыть анонс
16:15 AzoRobotics.comBiohybrid Robot Made from a Combination of Heart Tissue and 3D Printing

Taking inspiration from the toy shelf and biology, scientists at Thayer School of Engineering at Dartmouth College and City University of Hong Kong have built a swimming robot having a...

Скрыть анонс
16:10 ScienceDaily.comCancer drugs promote stem cell properties of colorectal cancer

Scientists have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells. This can lead to the accumulation of tumor cells with stem cell characteristics that are resistant to many therapies and can lead to relapses. The researchers thus provide a possible explanation for why these drugs are not effective in colorectal cancer.

Скрыть анонс
15:57 ScienceDaily.comCRISPR catches out critical cancer changes: New drug target for multiple cancers

In the first large-scale analysis of cancer gene fusions, researchers used CRISPR to uncover which gene fusions are critical for the growth of cancer cells. The team also identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian cancers. The results give more certainty for the use of specific gene fusions to diagnose and guide the treatment of patients.

Скрыть анонс
First← Previous12345678910Previous →Last